Status:
WITHDRAWN
Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from participating sleep clin...
Eligibility Criteria
Inclusion
- Self-reported race/ethnicity as African American, African, Caribbean or black
- Accessible by phone
- No plans to move away within the year
- OSA diagnosis, consent, including permission to release medical data
- Physician-diagnosed medical conditions.
Exclusion
- Progressive illnesses in which disability or death is expected within 1 year
- Impaired cognitive/ functional ability precluding participation
- Intention to move within the same year of enrollment
- Family member currently enrolled
Key Trial Info
Start Date :
June 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 18 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03354520
Start Date
June 18 2021
End Date
June 18 2021
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016